✦ LIBER ✦

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban — an Oral, Direct Factor Xa Inhibitor — in Patients Undergoing Major Orthopaedic Surgery

✍ Scribed by Dr Wolfgang Mueck, Bengt I. Eriksson, Kenneth A. Bauer, Lars Borris, Ola E. Dahl, William D. Fisher, Michael Gent, Sylvia Haas, Menno V. Huisman, Ajay K. Kakkar, Peter Kälebo, Louis M. Kwong, Frank Misselwitz, Alexander G. G. Turpie

Book ID: 119926856
Publisher: Springer International Publishing AG
Year: 2008
Tongue: English
Weight: 693 KB
Volume: 47
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200847030-00006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Tolerability, Pharmacodynamics,

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Rivaroxaban-an Oral, Direct Factor Xa Inhibitor-Are Not Affected by Aspirin

✍ Kubitza, Dagmar; Becka, Michael; Mueck, Wolfgang; Zuehlsdorf, Michael 📂 Article 📅 2006 🏛 Sage Publications 🌐 English ⚖ 139 KB

Effect of hepatic impairment on the phar

Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor

✍ Kubitza, Dagmar; Roth, Angelika; Becka, Michael; Alatrach, Abir; Halabi, Atef; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

Comparative Pharmacodynamics and Pharmac

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

✍ Dr Bengt I. Eriksson, Daniel J. Quinlan, Jeffrey I. Weitz 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 222 KB

Rivaroxaban – an oral, direct Factor Xa

Rivaroxaban – an oral, direct Factor Xa inhibitor – has potential for the management of patients with heparin-induced thrombocytopenia

✍ Jeanine M. Walenga; Margaret Prechel; Walter P. Jeske; Debra Hoppensteadt; Jyoth 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

Safety, pharmacodynamics, and pharmacoki

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects

✍ Dagmar Kubitza; Michael Becka; Georg Wensing; Barbara Voith; Michael Zuehlsdorf 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 768 KB

Prevention and treatment of experimental

Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939) – an oral, direct factor Xa inhibitor

✍ Biemond, Bart J.; Perzborn, Elisabeth; Friederich, Philip W.; Levi, Marcel; Buet 📂 Article 📅 2007 🏛 Schattauer 🌐 English ⚖ 899 KB